We are live on ! Find out more
Commonwealth Equity Services

Commonwealth Equity Services Portfolio holdings

AUM $71.6B
1-Year Est. Return 21.08%
This Fund
S&P 500
This Quarter Est. Return
+8.58%
1 Year Est. Return
+21.08%
3 Year Est. Return
+64.42%
5 Year Est. Return
+73.55%
10 Year Est. Return
+239.11%
AUM
$44.4B
AUM Growth
+$4.56B
Cap. Flow
+$1.39B
Cap. Flow %
3.14%
Top 10 Hldgs %
19.07%
Holding
3,821
New
246
Increased
1,953
Reduced
1,330
Closed
177

Sector Composition

Rank Sector Weight
1 Technology 12.61%
2 Financials 5.78%
3 Consumer Discretionary 5.1%
4 Healthcare 4.99%
5 Industrials 3.54%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AVGR
3526
DELISTED
Avinger, Inc. Common Stock
AVGR
$50K ﹤0.01%
374
+83
+29% +$16.4K
VIEW
3527
DELISTED
View, Inc. Class A Common Stock
VIEW
$50K ﹤0.01%
215
MAMA icon
3528
Mama's Creations
MAMA
$825M
$49K ﹤0.01%
24,600
+100
+0.4% +$226
ACGN
3529
DELISTED
Aceragen Inc
ACGN
$49K ﹤0.01%
5,103
ATOS icon
3530
Atossa Therapeutics
ATOS
$22.8M
$48K ﹤0.01%
2,029
+133
+7% +$4.87K
BKYI
3531
BIO-key International
BKYI
$4.94M
$48K ﹤0.01%
+122
New +$61.6K
IFRX icon
3532
InflaRx
IFRX
$256M
$48K ﹤0.01%
+10,100
New +$40.6K
UEC icon
3533
Uranium Energy
UEC
$4.71B
$48K ﹤0.01%
+14,529
New +$55.9K
MILE
3534
DELISTED
Metromile, Inc. Common Stock
MILE
$48K ﹤0.01%
22,355
-4,175
-16% -$11.9K
GSAT icon
3535
Globalstar
GSAT
$10.2B
$47K ﹤0.01%
2,728
+414
+18% +$9.07K
ARDS
3536
DELISTED
Aridis Pharmaceuticals Inc. Common Stock
ARDS
$47K ﹤0.01%
+20,200
New +$57.5K
ASMB icon
3537
Assembly Biosciences
ASMB
$506M
$46K ﹤0.01%
1,662
-30
-2% -$984
NNBR icon
3538
NN Inc
NNBR
$272M
$46K ﹤0.01%
11,265
QTTB icon
3539
Q32 Bio
QTTB
$450M
$46K ﹤0.01%
711
+58
+9% +$5.63K
TTOO
3540
DELISTED
T2 Biosystems, Inc
TTOO
$46K ﹤0.01%
18
+6
+50% +$20.9K
ANY icon
3541
Sphere 3D
ANY
$14.6M
$45K ﹤0.01%
+210
New +$81.4K
HOFV
3542
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$44K ﹤0.01%
1,342
+282
+27% +$13.3K
NGD
3543
DELISTED
New Gold Inc
NGD
$44K ﹤0.01%
29,779
+16,929
+132% +$24.4K
CTXR icon
3544
Citius Pharmaceuticals
CTXR
$14.3M
$43K ﹤0.01%
1,134
-239
-17% -$10.8K
BODI icon
3545
The Beachbody Company
BODI
$78.9M
$42K ﹤0.01%
362
+4
+1% +$771
SEEL
3546
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$42K ﹤0.01%
7
+1
+17% +$7.68K
NBEV
3547
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$42K ﹤0.01%
41,093
-2,220
-5% -$2.93K
TGB
3548
Trekor Metals
TGB
$2.56B
$40K ﹤0.01%
19,595
VTGN icon
3549
VistaGen Therapeutics
VTGN
$9.29M
$40K ﹤0.01%
690
-95
-12% -$6.18K
CCO icon
3550
Clear Channel Outdoor Holdings
CCO
$1.23B
$39K ﹤0.01%
12,041

Similar funds

Commonwealth Equity Services's Q4 2021 Portfolio in Review

As of Q4 2021, Commonwealth Equity Services held 3,821 positions worth $44.4B, up 11% from $39.8B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Commonwealth Equity Services deployed $1.39B of net new capital in Q4 2021, opening 246 new positions and adding to 1,953 existing holdings. Its largest new stake was First Trust Nasdaq Oil & Gas ETF: 960,334 shares worth $18.7M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Gold Trust, an estimated $27.2M trimmed.

  • Commonwealth Equity Services's largest Q4 2021 buy was First Trust Nasdaq Oil & Gas ETF: 960,334 shares worth $18.7M.
  • Commonwealth Equity Services added most to iShares ESG Aware MSCI USA ETF in Q4 2021, an estimated $54M increase.
  • Commonwealth Equity Services's biggest Q4 2021 reduction was iShares Gold Trust, cutting an estimated $27.2M.
  • Commonwealth Equity Services fully exited PIMCO Dynamic Credit and Mortgage Income Fund in Q4 2021, selling an estimated $9.53M.
  • Commonwealth Equity Services's ten largest holdings make up 19% of its $44.4B portfolio in Q4 2021.
  • Commonwealth Equity Services opened 246 new positions and closed 177 in Q4 2021.
  • Commonwealth Equity Services's portfolio value rose 11% quarter-over-quarter to $44.4B.

Based on Commonwealth Equity Services's 13F filing for Q4 2021, filed 31 Jan 2022.